These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27537734)

  • 1. Bosentan for digital ulcers prevention does not worsen cardiopulmonary exercise test parameters in SSc patients with interstitial lung disease.
    Romaniello A; Gigante A; Di Paolo M; Tallerini G; Barbano B; Amoroso D; Palange P; Rosato E
    Int J Cardiol; 2016 Nov; 223():113-115. PubMed ID: 27537734
    [No Abstract]   [Full Text] [Related]  

  • 2. Bosentan in systemic sclerosis.
    Heresi GA; Minai OA
    Drugs Today (Barc); 2008 Jun; 44(6):415-28. PubMed ID: 18596996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis: Prospective, multicenter, open-label study.
    Hamaguchi Y; Sumida T; Kawaguchi Y; Ihn H; Tanaka S; Asano Y; Motegi SI; Kuwana M; Endo H; Takehara K
    J Dermatol; 2017 Jan; 44(1):13-17. PubMed ID: 27374274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
    Korn JH; Mayes M; Matucci Cerinic M; Rainisio M; Pope J; Hachulla E; Rich E; Carpentier P; Molitor J; Seibold JR; Hsu V; Guillevin L; Chatterjee S; Peter HH; Coppock J; Herrick A; Merkel PA; Simms R; Denton CP; Furst D; Nguyen N; Gaitonde M; Black C
    Arthritis Rheum; 2004 Dec; 50(12):3985-93. PubMed ID: 15593188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New hope for systemic sclerosis patients with digital ulcers.
    Varga J
    Curr Rheumatol Rep; 2005 Apr; 7(2):127-8. PubMed ID: 15760591
    [No Abstract]   [Full Text] [Related]  

  • 6. Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study.
    Cozzi F; Pigatto E; Rizzo M; Favaro M; Zanatta E; Cardarelli S; Riato L; Punzi L
    Clin Rheumatol; 2013 May; 32(5):679-83. PubMed ID: 23344686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists.
    Ngcozana T; Ong V; Denton CP
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24682137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
    Matucci-Cerinic M; Denton CP; Furst DE; Mayes MD; Hsu VM; Carpentier P; Wigley FM; Black CM; Fessler BJ; Merkel PA; Pope JE; Sweiss NJ; Doyle MK; Hellmich B; Medsger TA; Morganti A; Kramer F; Korn JH; Seibold JR
    Ann Rheum Dis; 2011 Jan; 70(1):32-8. PubMed ID: 20805294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connective tissue diseases: Treatment of digital ulcers in systemic sclerosis.
    Lambova S; Müller-Ladner U
    Nat Rev Rheumatol; 2011 Jan; 7(1):5-6. PubMed ID: 21119606
    [No Abstract]   [Full Text] [Related]  

  • 10. Digital Ulcers, Systemic Sclerosis Sine Scleroderma and Paraneoplastic Phenomena Responding to Bosentan Therapy.
    Sharabi I; Tanay A; Zandman-Goddard G
    Isr Med Assoc J; 2015 Feb; 17(2):126-7. PubMed ID: 26223094
    [No Abstract]   [Full Text] [Related]  

  • 11. Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis.
    Dhillon S
    Drugs; 2009 Oct; 69(14):2005-24. PubMed ID: 19747014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan.
    Humbert M; Cabane J
    Rheumatology (Oxford); 2003 Jan; 42(1):191-3. PubMed ID: 12509640
    [No Abstract]   [Full Text] [Related]  

  • 13. [Digital ulcers in systemic sclerosis : A retrospective heath service study analysing treatment with bosentan and other vasoactive therapies].
    Riemekasten G; Beissert S; Distler JH; Kreuter A; Müller-Ladner U
    Z Rheumatol; 2017 Apr; 76(3):228-237. PubMed ID: 27535277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval.
    Agard C; Carpentier PH; Mouthon L; Clerson P; Gressin V; Bérezné A; Diot E; Jego P; Lok C; Sparsa A; Chatelus E; Van Kien AK; Quéré I; Sibilia J; Hachulla E
    Scand J Rheumatol; 2014; 43(5):398-402. PubMed ID: 24720440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bosentan for treatment of active digital ulcers in patients with systemic sclerosis].
    Launay D; Diot E; Pasquier E; Mouthon L; Boullanger N; Fain O; Jego P; Carpentier P; Hatron PY; Hachulla E
    Presse Med; 2006 Apr; 35(4 Pt 1):587-92. PubMed ID: 16614599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers.
    Jain M; Varga J
    Expert Opin Pharmacother; 2006 Aug; 7(11):1487-501. PubMed ID: 16859432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)].
    Riccardi MT; Chialà A; Lannone F; Grattagliano V; Covelli M; Lapadula G
    Reumatismo; 2007; 59(2):135-9. PubMed ID: 17603693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease.
    Ahmadi-Simab K; Hellmich B; Gross WL
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():44-8. PubMed ID: 16919010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis.
    Sfikakis PP; Papamichael C; Stamatelopoulos KS; Tousoulis D; Fragiadaki KG; Katsichti P; Stefanadis C; Mavrikakis M
    Arthritis Rheum; 2007 Jun; 56(6):1985-93. PubMed ID: 17530638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In systemic sclerosis patients, bosentan is safe and effective for digital ulcer prevention and it seems to attenuate the development of pulmonary arterial hypertension.
    Romaniello A; Viola G; Salsano F; Rosato E
    Rheumatology (Oxford); 2014 Mar; 53(3):570-1. PubMed ID: 24357809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.